Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

1.0K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

513
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
513
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.6K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.5K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.5K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

1.2K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

562
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2026 Update on Outcomes and Research.

The Annals of thoracic surgery·2026
Same author

Rare type I collagen variants in early-onset bicuspid aortic valve disease: Overlap with Ehlers-Danlos syndrome and osteogenesis imperfecta.

HGG advances·2026
Same author

The surgical management of mediastinal paragangliomas: A modern series reflecting true collaboration between cardiac and thoracic surgeons.

JTCVS open·2026
Same author

The Society of Thoracic Surgeons 2026 Clinical Practice Guidelines for the Prevention and Treatment of New-Onset Postoperative Atrial Fibrillation After Cardiac Surgery.

The Annals of thoracic surgery·2026
Same author

Representativeness in coronary revascularization trials: Beyond demographics.

JTCVS open·2026
Same author

Wire puncture technique for placement of perfusion sheath during venous-arterial extracorporeal membrane oxygenation.

The journal of vascular access·2026

Related Experiment Video

Updated: Apr 18, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

7.8K

Concurrent aortic valvular disease and pulmonary sequestration: clinical implications.

Dawn S Hui, David M Shavelle, Vaughn A Starnes

    Texas Heart Institute Journal
    |January 17, 2015
    PubMed
    Summary

    Pulmonary sequestration, a lung condition, poses risks when combined with heart valve disease. Treatment decisions for these concurrent conditions require careful, individualized cardiac risk assessment.

    Keywords:
    Abnormalities, multiple/diagnosisbronchopulmonary sequestration/complications/diagnosis/surgeryendocarditis, bacterial/complications/etiology/pathologyheart valve diseases/etiologylung/blood supplytreatment outcome

    More Related Videos

    Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
    07:41

    Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

    Published on: February 8, 2022

    4.6K
    Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
    09:22

    Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

    Published on: November 4, 2015

    12.7K

    Related Experiment Videos

    Last Updated: Apr 18, 2026

    Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
    08:34

    Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

    Published on: November 18, 2018

    7.8K
    Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
    07:41

    Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

    Published on: February 8, 2022

    4.6K
    Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
    09:22

    Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

    Published on: November 4, 2015

    12.7K

    Area of Science:

    • Cardiology
    • Thoracic Surgery
    • Pulmonology

    Background:

    • Pulmonary sequestration is a congenital lung malformation lacking normal bronchial and vascular connections.
    • In adults, pulmonary sequestration often leads to recurrent infections, with surgical resection (sequestrectomy) being a common treatment.
    • Concurrent valvular heart disease with pulmonary sequestration presents unique challenges due to altered venous drainage and potential for infective endocarditis or volume overload.

    Observation:

    • This study details two adult cases of concurrent pulmonary sequestration and aortic valvular disease.
    • One patient was symptomatic, the other asymptomatic, highlighting varied clinical presentations.
    • Evaluation focused on assessing cardiac risk and guiding treatment strategies for these complex cases.

    Findings:

    • No established guidelines exist for managing pulmonary sequestration alongside valvular heart disease.
    • Venous drainage patterns of sequestra can increase risks of infective endocarditis and volume overload in cardiac patients.
    • Individualized assessment of cardiac risk is crucial for treatment decisions.

    Implications:

    • Management of concurrent pulmonary sequestration and valvular heart disease requires a tailored, case-by-case approach.
    • Further research is needed to establish predictive models for cardiac risk in these patients.
    • This approach emphasizes multidisciplinary collaboration between cardiology and thoracic surgery specialists.